Clinical Trials

Accrual Status
Limit to SWOG Trials

1044 Results

View
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
S1207

Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer. e3 Breast Cancer Study- evaluating everolimus with endocrine therapy.
Status Notes
S1207 will be permanently closed to accrual effective May 1, 2019 at 11:59 p.m. Pacific Time.

Effective 12/15/18, with the distribution of Revision #11 (Version Date 10/24/18), procedures for planned unblinding are now included in Section 7.5 of the protocol.
Research Committee(s)
Breast Cancer
Activated
09-03-2013
Closed
05-01-2019
ClinicalTrials.gov Registry Number
NCT01674140
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
S1204

A Sero-Epidemiologic Survey and Cost-effectiveness Study of Screening for Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Among Newly Diagnosed Cancer Patients
Status Notes
This study closed to patient accrual 2/15/17.
Research Committee(s)
Cancer Care Delivery
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Leukemia
Lung Cancer
Lymphoma
Melanoma
Myeloma
Activated
08-29-2013
Closed
02-15-2017
ClinicalTrials.gov Registry Number
NCT01946516
Closed
Phase
Accrual
39%
SWOG Clinical Trial Number
S1221

"Phase I/II Study of the Safety and Efficacy of the AKT Inhibitor GSK2141795 in Combination with Dabrafenib and Trametinib in Patients with BRAF Mutant Cancer."
Status Notes
The study referenced above was temporarily closed to accrual on 10/31/2016.
Due to drug supply on this study, the study will be switched from temporarily closed to permanently closed with the same status date of 10/31/2016.
Research Committee(s)
Melanoma
Gastrointestinal Cancer
Leukemia
Activated
07-01-2013
ClinicalTrials.gov Registry Number
NCT01902173
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1202

A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor (AI)-Associated Musculoskeletal Symptoms in Women with Early Stage Breast Cancer
Status Notes
This protocol will be permanently closed to accrual effective 10/1/15.
Research Committee(s)
Symptom Management and Survivorship
Breast Cancer
Activated
05-15-2013
Closed
10-01-2015
ClinicalTrials.gov Registry Number
NCT01598298
Closed
Phase
Accrual
91%
SWOG Clinical Trial Number
S0820

A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients with Stage 0-III Colon or Rectal Cancer, Phase III - Preventing Adenomas of the Colon with Eflornithine and Sulindac (PACES)"
Research Committee(s)
Prevention, Screening, and Surveillance
Gastrointestinal Cancer
Activated
03-01-2013
ClinicalTrials.gov Registry Number
NCT01349881
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
S1216

A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 with Androgen Deprivation Therapy + Bicalutamide in Patients with Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer
Research Committee(s)
Genitourinary Cancer
Activated
03-01-2013
Closed
07-15-2017
ClinicalTrials.gov Registry Number
NCT01809691
Closed
Phase
Accrual
96%
SWOG Clinical Trial Number
S1203

A Randomized Phase III Study of Standard Cytarabine Plus Daunomycin (7+3) Therapy versus Idarubicin with High Dose Cytarabine (IA) with or without Vorinostat (IA+V) in Younger Patients with Previously Untreated Acute Myeloid Leukemia (AML)
Status Notes
S1203 will permanently close to accrual on 11/4/15 at 11:59pm Pacific Time.
Research Committee(s)
Leukemia
Activated
12-15-2012
Closed
11-04-2015
ClinicalTrials.gov Registry Number
NCT01802333
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
S1211

A Randomized Phase I/II Study of Optimal Induction Therapy of Bortezomib, Dexamethasone and Lenalidomide with or without Elotuzumab (NSC-764479) for Newly Diagnosed High Risk Multiple Myeloma (HRMM)
Status Notes
This study was temporarily closed to accrual on June 2, 2016 at 11:59 p.m. Pacific.
Research Committee(s)
Myeloma
Activated
10-12-2012
ClinicalTrials.gov Registry Number
NCT01668719
Closed
Phase
Accrual
71%
SWOG Clinical Trial Number
S1107

Parallel (Randomized) Phase II Evaluation of ARQ 197 and ARQ 197 in Combination with Erlotinib in Papillary Renal Cell Carcinoma
Research Committee(s)
Genitourinary Cancer
Activated
08-20-2012
Closed
05-29-2014
ClinicalTrials.gov Registry Number
NCT01688973
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1115

Randomized Phase II Clinical Trial of AZD6244 Hydrogen Sulfate (NSC-748727) and MK-2206 (NSC-749607) vs. mFOLFOX in Patients with Metastatic Pancreatic Cancer after Prior Chemotherapy
Research Committee(s)
Gastrointestinal Cancer
Activated
08-15-2012
Closed
05-15-2014
ClinicalTrials.gov Registry Number
NCT01658943
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
S1105

Randomized Trial Of A Text-Messaging Intervention To Reduce Early Discontinuation Of Adjuvant Aromatase Inhibitor Therapy In Women With Early Stage Breast Cancer
Research Committee(s)
Cancer Care Delivery
Breast Cancer
Activated
03-27-2012
Closed
09-15-2013
ClinicalTrials.gov Registry Number
NCT01515800
Closed
Phase
Accrual
99%
SWOG Clinical Trial Number
S1200

Randomized Blinded Sham- and Waitlist-Controlled Trial of Acupuncture for Joint Symptoms Related to Aromatase Inhibitors in Women with Early Stage Breast Cancer
Status Notes
Effective 11:59 Pacific Time on February 15th, 2017, S1200 will be permanently closed to accrual.
Research Committee(s)
Symptom Management and Survivorship
Breast Cancer
Activated
03-27-2012
ClinicalTrials.gov Registry Number
NCT01535066
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
S1008

Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II
Research Committee(s)
Cancer Survivorship
Breast Cancer
Gastrointestinal Cancer
Activated
03-01-2012
Closed
07-01-2014
ClinicalTrials.gov Registry Number
NCT01453452
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1117

A Randomized Phase II Study of Azacitidine in Combination with Lenalidomide (NSC-703813) vs. Azacitidine Alone vs. Azacitidine in Combination with Vorinostat (NSC-701852) for Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
Research Committee(s)
Leukemia
Activated
03-01-2012
Closed
11-14-2014
ClinicalTrials.gov Registry Number
NCT01522976
Closed
Phase
Accrual
95%
SWOG Clinical Trial Number
S1201

A Randomized Phase II Pilot Study Prospectively Evaulating Treatment for Patients Based on ERCC1 (Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
02-08-2012
Closed
04-01-2015
ClinicalTrials.gov Registry Number
NCT01498289
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0927

Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain in Women with Early Stage Breast Cancer, Phase III
Research Committee(s)
Symptom Management and Survivorship
Breast Cancer
Activated
02-01-2012
Closed
02-01-2013
ClinicalTrials.gov Registry Number
NCT01385137
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1119

Gastric Cancer and Helicobacter Pylori Infection in Lima, Peru: The Role of Water Contamination
Research Committee(s)
Prevention, Screening, and Surveillance
Activated
12-02-2011
Closed
08-05-2013
ClinicalTrials.gov Registry Number
NCT01512875
Closed
Phase
Accrual
94%
SWOG Clinical Trial Number
S1013

A Phase II Prospective Study of Epidermal Growth Factor Receptor (Her-1/EGFR) Inhibitor-Induced Dermatologic Toxicity: Validation of the Functional Assessment of Cancer Therapy � EGFRI 18 (FACT-EGFRI 18) Questionnaire for EGFRI-induced Skin Toxicities
Status Notes
This study will be permanently closed to accrual on October 1, 2016, at 11:59 p.m. Pacific.
Research Committee(s)
Symptom Management and Survivorship
Gastrointestinal Cancer
Lung Cancer
Activated
11-15-2011
Closed
10-01-2016
ClinicalTrials.gov Registry Number
NCT01416688
Closed
Phase
Accrual
95%
SWOG Clinical Trial Number
S0812

“Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer."
Research Committee(s)
Prevention, Screening, and Surveillance
Breast Cancer
Activated
11-01-2011
Closed
08-15-2014
ClinicalTrials.gov Registry Number
NCT01097278
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1108

Phase II Trial of the Aurora Kinase A Inhibitor, MLN8237, in Peripheral T-Cell Non-Hodgkin Lymphoma
Research Committee(s)
Lymphoma
Activated
10-28-2011
Closed
06-06-2013